Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Former Holly Hill employees share concerns about patient safety, citing escapes and understaffing
Recommended
'He needs to step up': Some top NC Democrats raise concerns over Biden
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cassava Sciences Inc
(NQ:
SAVA
)
9.840
-0.380 (-3.72%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cassava Sciences Inc
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
UK Authority Approves Microsoft's $69B Activision Blizzard Acquisition, Google Search Gets Generative AI Boost, Big Banks Earnings: Today's Top Stories
October 13, 2023
Benzinga
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 13, 2023
Via
Benzinga
Alzheimer's-Focused Cassava Sciences Faces Controversy as Key Collaborator Accused of Scientific Misconduct
October 13, 2023
Cassava Sciences Inc (NASDAQ: SAVA), the Alzheimer-focused firm, is facing further controversy as a recent investigation by the City University of New York (CUNY) has implicated neuroscientist Hoau-Yan...
Via
Benzinga
Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
October 13, 2023
Gainers Oblong, Inc. (NASDAQ: OBLG) shares rose 295.7% to $1.16 in pre-market trading.
Via
Benzinga
Why Cassava Sciences Stock Is Trading Down Today
July 05, 2023
Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading lower Wednesday.
Via
Benzinga
Outset Medical, SMART Global And Other Big Stocks Moving Lower In Friday's Pre-Market Session
October 13, 2023
U.S. stock futures traded lower this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Statement by Cassava Sciences Regarding an Internal CUNY Report Leaked to the Press
October 12, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
October 12, 2023
Via
Benzinga
Why Shares of Cassava Sciences Soared This Week
October 06, 2023
Cassava bounced back from hitting a 52-week low to start the week.
Via
The Motley Fool
Cassava Sciences to Present at the Jefferies Biotech CNS/Neuro Summit in NY
October 05, 2023
CEO to Present on Wednesday, October 11th, at 10:30am ET
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
October 02, 2023
On Monday, 369 companies set new 52-week lows.
Via
Benzinga
Cassava Sciences Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Oral Simufilam in Alzheimer’s Disease
October 02, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease
September 18, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
The 7 Best Meme Stocks to Buy Now: September 2023
September 14, 2023
Consider these seven past and present faves of the Reddit set to be the best meme stocks to buy this month.
Via
InvestorPlace
Jim Cramer Says No To This Fintech Titan With Declining Margins: 'I Think It's A Value Trap'
September 12, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ONEOK, Inc's (NYSE: OKE) management is terrific. "The CFO Walter Hulse is like you and me, a Jersey-ite.
Via
Benzinga
Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimer’s Disease
September 11, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Invited to Present in Four Upcoming Investor Conferences
September 06, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Snowflake (SNOW) Stock Is Sliding Despite AI Hopes
August 24, 2023
Snowflake (SNOW) stock is on the move Thursday following the release of the company's second-quarter earnings report for fiscal 2024.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is Splunk (SPLK) Stock the Next AI Giant?
August 24, 2023
Splunk (SPLK) stock climbed higher on Thursday as investors weighed the company's value in the AI market following its earnings report.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Insider Richard Barry Just Doubled Down on Cassava (SAVA) Stock
August 24, 2023
Cassava had $168.4 million of cash at the end of June after losing $28.7 million during the second quarter of 2023. SAVA stock is up 5%
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 14, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
During the Friday's sesion, 157 stocks hit new 52-week lows.
Via
Benzinga
Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates
August 03, 2023
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now
July 13, 2023
These three worst biotech stocks are not investable even if you're bullish on the sector overall. There are better options.
Via
InvestorPlace
7 Biotech Stocks to Sell in July
July 13, 2023
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.
Via
InvestorPlace
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
July 07, 2023
The FDA fully approved Biogen Inc.’s (NASDAQ: BIIB) Alzheimer’s treatment Leqembi on Thursday, becoming the first Alzheimer’s antibody treatment to reach full approval.
Via
Benzinga
Stock Market Round-Up: Rivian Rides High, Meta Platforms Makes Moves, And Tesla Ticks Up
July 05, 2023
Via
Benzinga
Cassava Sciences (SAVA) Stock Drops Despite Positive Trial Results
July 05, 2023
Cassava Sciences (SAVA) stock is down 11% on underwhelming results from its Phase 3 clinical trials for its Alzheimer's treatment.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 05, 2023
Via
Benzinga
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 05, 2023
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.